BioConverGene Technologies Corporation
The BioConverGene Accelerator opens its doors to harness Life Science Innovation in Eastern Ottawa
Press Release Date:
BioConverGene Accelerator: providing a common venue for product design and development, public understanding, health promotion and showcasing emerging technologies
Powering functional innovation in Canada is not a luxury; it is an urgent prerequisite to securing our technological independence and capacity, economic diversity and strength. Since its inception in 2004 and as a result of several Team Canada trade missions, the International Centre for the Advancement of Health, Regional Innovation and Science (ICAHRIS / CIASIRS) has been involved in harnessing regional innovation and competitiveness by enabling the creation of regional start-up and spin-off enterprises while fostering collaborative undertakings with well-established local small and medium size enterprises (SMEs).
Located in Ottawa, ICAHRIS / CIASIRS also has a significant interest in facilitating public knowledge and understanding of emerging biological and related technologies, products and services within the life sciences and associated sectors affecting human and environmental health. In the last two years, ICHARIS / CIASIRS has been directly involved in the creation of BioConverGene Technologies Corporation and iBioSign Health Integrated Systems Corporation, two Research and Development ventures focused upon developing new products and services tailored to maintaining and enhancing human health and primary and secondary disease prevention. Key areas of interest involve neuronal, adult and mature stem cells, neurodegenerative diseases and associated ailments, obesity, type 2 diabetes, inflammation, cancer and integrative medical devices among other related products and services primarily addressing women's health.
From June 24 to June 26, the public took part in a three-day open house event at the BioConverGene Accelerator, a 5000 square feet facility located at 5380 Canotek Road, Units 1 and 3, in Eastern Ottawa. Throughout the entire three days, visitors were introduced to two innovations, the Health Profile Navigator and the conceptual platform of the Sound-Induced Signature Motifs and Neurotransmission Pathways .
After two years of developing and testing, the first generation of the Health Profile Navigator was showcased and released. The Health Profile Navigator is an intuitive, easy to use, correlational, interactive tool designed to provide the end user the capacity to securely enter and retrieve a comprehensive record of the user's health status anytime, anywhere in the world, either for personal reasons or for use in case of an emergency requiring medical attention and treatment. In the case of otherwise healthy end users, the Health Profile Navigator provides several unique capabilities to periodically, objectively and quantitatively access and verify the user's health profile, acting as a sentinel tool for primary disease prevention. With the consent of the end user, health practitioners have the ability to rapidly access a comprehensive, single point, up-to-date health profile record, enabling them to better assess and determine the most suitable course of action in case the user is in need of professional medical attention.
During the open house, visitors also had the opportunity to explore and better understand the concept of a quantitative interactive tool, the Sound-Induced Signature Motifs and Neurotransmission Pathways. Currently being adapted to provide an objective and quantitative assessment of changes in both behavioural and metabolic patterns, this tool is being developed to be a sentinel parameter to better assess the early onset of pre-partum and post-partum depression, among other mental illnesses affecting the health of women. Developed by Dr Gabriel Pulido-Cejudo, CEO of BioConverGene Technologies Corporation, the first seven original sound tracks to be used in the Sound-Induced Signature Motifs and Neurotransmission Pathways tool were created in collaboration with Ottawa's acclaimed cello player and composer, Margaret Maria. During the open house at the BioConverGene Accelerator, Margaret Maria and Dr Gabriel Pulido-Cejudo signed a limited edition of their first CD, entitled Believe: Sound-Induced Signature Motifs.
Dr Gabriel Pulido-Cejudo Ph.D.
Press Release Highlights
Download the press release: July 3, 2015, Press Release